Evidence map›Paper›PMID 34262028›Full record

ArticleNature communications2021

The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling.

Eui Jung Moon, Stephano S Mello, Caiyun G Li, Jen-Tsan Chi, Kaushik Thakkar, Jacob G Kirkland, Edward L Lagory, Ik Jae Lee, Anh N Diep, Yu Miao and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Review
  3. Gut · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Pan-cancer analysis reveals TREM1Communications biology · 2025
    Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Eui Jung MoonDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Stephano S MelloDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Caiyun G LiDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Jen-Tsan ChiDepartment of Molecular Genetics and Microbiology, Duke University, Durham, NC, USA.ORCID 0000-0003-3433-903X
Kaushik ThakkarDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.ORCID 0000-0002-4900-3371
Jacob G KirklandDepartment of Pathology, Department of Developmental Biology, Stanford University, Stanford, CA, USA.ORCID 0000-0001-5617-7065
Edward L LagoryDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Ik Jae LeeDepartment of Radiation Oncology, Yonsei Cancer Center, Seoul, Republic of Korea.
Anh N DiepDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Yu MiaoDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Marjan RafatDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.ORCID 0000-0002-9444-4379
Marta VilaltaDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Laura CastelliniDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Adam J KriegDepartment of Obstetrics and Gynecology, Oregon Health and Sciences University, Portland, OR, USA.ORCID 0000-0002-3069-0378
Edward E GravesDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.ORCID 0000-0003-4265-9041
Laura D AttardiDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Amato J GiacciaDivision of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA. giaccia@stanford.edu.ORCID 0000-0002-1940-2750
Stanford University · USUniversity of Oxford · GBDuke University · USOklahoma Medical Research Foundation · USOregon Health & Science University · USUniversity of Rochester Medical Center · USVanderbilt University · USYonsei University · KR

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
TUMOR HYPOXIA--MOLECULAR STUDIES &CLINICAL EXPLOITATIONP01CA067166 · NCI · STANFORD UNIVERSITY · PI LE, QUYNH-THU XUAN · 1996 to 2017
$25.5M
Leveraging innovative technologies in basic and clinical cancer researchT32CA009302 · NCI · STANFORD UNIVERSITY · PI LAURA D ATTARDI, Aaron M Newman · 1985 to 2026
$19.1M
Medical Research Council MC_UU_00001/11Medical Research Council MC_UU_00001/8NCI NIH HHS P01 CA067166NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA124435NCI NIH HHS T32 CA009302
6 · The paper itself

Abstract

Hypoxia plays a critical role in tumor progression including invasion and metastasis. To determine critical genes regulated by hypoxia that promote invasion and metastasis, we screen fifty hypoxia inducible genes for their effects on invasion. In this study, we identify v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (MAFF) as a potent regulator of tumor invasion without affecting cell viability. MAFF expression is elevated in metastatic breast cancer patients and is specifically correlated with hypoxic tumors. Combined ChIP- and RNA-sequencing identifies IL11 as a direct transcriptional target of the heterodimer between MAFF and BACH1, which leads to activation of STAT3 signaling. Inhibition of IL11 results in similar levels of metastatic suppression as inhibition of MAFF. This study demonstrates the oncogenic role of MAFF as an activator of the IL11/STAT3 pathways in breast cancer.

Indexed as

AnimalsBasic-Leucine Zipper Transcription FactorsBreast NeoplasmsCell HypoxiaCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitInterleukin-11MafF Transcription FactorMiceNeoplasm InvasivenessNeoplasm MetastasisNuclear ProteinsPrognosisBACH1 protein, humanBasic-Leucine Zipper Transcription FactorsHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIL11 protein, humanInterleukin-11MAFF protein, humanMafF Transcription FactorNuclear ProteinsSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID34262028
PMCPMC8280233
OpenAlexW3179658109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.